Pathogenic mutations in UBQLN2 exhibit diverse aggregation propensity and neurotoxicity

Area of Science:

• Molecular Biology
• Neuroscience
• Genetics

Background:

• UBQLN2 protein is crucial for degrading proteins prone to aggregation, which are implicated in neurodegenerative diseases.
• Mutations in UBQLN2 are linked to X-linked amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• Previous research showed a specific mutation (P506T) alters UBQLN2 assembly properties and links aggregation to neurotoxicity.

Purpose of the Study:

• To investigate the impact of various ALS/FTD-linked UBQLN2 mutations on protein aggregation, neurotoxicity, phase separation, and autophagic flux.
• To determine if a generalizable correlation exists between UBQLN2 aggregation propensity and neurodegeneration across different pathogenic mutations.

Main Methods:

• Systematic assessment of multiple UBQLN2 mutations.
• Evaluation of aggregation propensity, neurotoxicity, phase separation, and autophagic flux.
• Comparative analysis of mutation effects, focusing on the P506T mutation as a reference.

Main Results:

• No clear correlation between aggregation propensity and neurotoxicity was observed for most tested pathogenic UBQLN2 mutants.
• The P506T mutation's link between aggregation and neurotoxicity appears unique among the studied mutations.
• The study highlights the distinct nature of different UBQLN2 mutations in the context of neurodegeneration.

Conclusions:

• The findings suggest that a generalizable link between UBQLN2 aggregation and neurodegeneration in ALS/FTD may not exist.
• Pathogenic UBQLN2 mutations exhibit unique effects, challenging a one-size-fits-all model for UBQLN2-related neurodegenerative diseases.